Summit Securities Group’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $92.7K | Sell |
896
-113
| -11% | -$10.1K | 0.01% | 423 |
|
|
2026
Q1 | $72.5K | Sell |
1,009
-17,877
| -95% | -$1.38M | 0.01% | 328 |
|
|
2025
Q4 | $1.5M | Buy |
18,886
+10,498
| +125% | +$828K | 0.2% | 91 |
|
|
2025
Q3 | $632K | Buy |
8,388
+7,536
| +885% | +$516K | 0.13% | 148 |
|
|
2025
Q2 | $58.8K | Buy |
+852
| New | +$55.9K | 0.01% | 491 |
|
|
2024
Q3 | – | Sell |
-2,536
| Closed | -$150K | – | 642 |
|
|
2024
Q2 | $150K | Buy |
+2,536
| New | +$159K | 0.03% | 185 |
|
|
2024
Q1 | – | Sell |
-300
| Closed | -$24K | – | 550 |
|
|
2023
Q4 | $24K | Buy |
300
+100
| +50% | +$7.12K | ﹤0.01% | 461 |
|
|
2023
Q3 | $14K | Sell |
200
-1,776
| -90% | -$126K | ﹤0.01% | 391 |
|
|
2023
Q2 | $137K | Sell |
1,976
-842
| -30% | -$59.9K | 0.02% | 254 |
|
|
2023
Q1 | $209K | Sell |
2,818
-12,610
| -82% | -$1.06M | 0.02% | 213 |
|
|
2022
Q4 | $1.44M | Sell |
15,428
-7,462
| -33% | -$720K | 0.05% | 146 |
|
|
2022
Q3 | $2.18M | Buy |
22,890
+3,349
| +17% | +$332K | 0.16% | 88 |
|
|
2022
Q2 | $1.81M | Sell |
19,541
-37,496
| -66% | -$3.66M | 0.23% | 79 |
|
|
2022
Q1 | $5.77M | Sell |
57,037
-40,501
| -42% | -$4.25M | 0.65% | 26 |
|
|
2021
Q4 | $10.1M | Buy |
97,538
+71,038
| +268% | +$6.56M | 0.47% | 39 |
|
|
2021
Q3 | $2.25M | Sell |
26,500
-15,517
| -37% | -$1.3M | 0.18% | 136 |
|
|
2021
Q2 | $3.51M | Buy |
42,017
+19,717
| +88% | +$1.61M | 0.29% | 78 |
|
|
2021
Q1 | $1.68M | Sell |
22,300
-3,000
| -12% | -$219K | 0.18% | 121 |
|
|
2020
Q4 | $1.73M | Buy |
25,300
+2,300
| +10% | +$150K | 0.15% | 168 |
|
|
2020
Q3 | $1.34M | Sell |
23,000
-30,400
| -57% | -$1.89M | 0.14% | 126 |
|
|
2020
Q2 | $3.47M | Buy |
53,400
+12,500
| +31% | +$787K | 0.43% | 46 |
|
|
2020
Q1 | $2.43M | Buy |
40,900
+10,800
| +36% | +$721K | 0.43% | 52 |
|
|
2019
Q4 | $2.24M | Sell |
30,100
-6,500
| -18% | -$456K | 0.17% | 127 |
|
|
2019
Q3 | $2.31M | Buy |
36,600
+29,900
| +446% | +$1.77M | 0.2% | 76 |
|
|
2019
Q2 | $365K | Buy |
+6,700
| New | +$361K | 0.04% | 238 |
|
|
2019
Q1 | – | Sell |
-43,000
| Closed | -$2.65M | – | 227 |
|
|
2018
Q4 | $2.82M | Buy |
43,000
+35,900
| +506% | +$2.68M | 0.24% | 65 |
|
|
2018
Q3 | $559K | Buy |
7,100
+3,400
| +92% | +$243K | 0.21% | 77 |
|
|
2018
Q2 | $238K | Buy |
+3,700
| New | +$244K | 0.03% | 193 |
|
|
2017
Q2 | – | Sell |
-10,047
| Closed | -$789K | – | 267 |
|
|
2017
Q1 | $789K | Buy |
+10,047
| New | +$802K | 0.23% | 93 |
|
|
2016
Q1 | – | Sell |
-13,500
| Closed | -$1.32M | – | 184 |
|
|
2015
Q4 | $1.32M | Buy |
13,500
+12,100
| +864% | +$1.19M | 0.43% | 40 |
|
|
2015
Q3 | $135K | Sell |
1,400
-2,772
| -66% | -$291K | 0.1% | 100 |
|
|
2015
Q2 | $438K | Buy |
4,172
+3,872
| +1,291% | +$396K | 0.21% | 36 |
|
|
2015
Q1 | $31K | Sell |
300
-1,600
| -84% | -$162K | 0.02% | 231 |
|
|
2014
Q4 | $183K | Sell |
1,900
-200
| -10% | -$17.6K | 0.05% | 202 |
|
|
2014
Q3 | $167K | Buy |
2,100
+600
| +40% | +$47.3K | 0.05% | 232 |
|
|
2014
Q2 | $113K | Buy |
1,500
+900
| +150% | +$68K | 0.04% | 218 |
|
|
2014
Q1 | $45K | Sell |
600
-3,000
| -83% | -$212K | 0.03% | 189 |
|
|
2013
Q4 | $258K | Buy |
+3,600
| New | +$231K | 0.04% | 152 |
|
|
2013
Q3 | – | Sell |
-400
| Closed | -$23K | – | 450 |
|
|
2013
Q2 | $23K | Buy |
+400
| New | +$23.2K | 0.01% | 234 |
|
Other funds holding CVS
Summit Securities Group's CVS Position: Q2 2026 in Review
Summit Securities Group reduced its CVS Health (CVS) stake by 11% in Q2 2026, selling an estimated $10.1K and leaving 896 shares worth $92.7K. The position accounts for 0.01% of the portfolio, ranked #423.
Summit Securities Group first reported a position in CVS in Q2 2013 and has held it in 39 quarters since. The position peaked at $10.1M in Q4 2021. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Summit Securities Group held 896 shares of CVS Health worth $92.7K as of Q2 2026.
- Summit Securities Group sold 113 CVS Health shares in Q2 2026, an estimated $10.1K.
- CVS Health made up 0.01% of Summit Securities Group's portfolio in Q2 2026, its #423 holding.
- Summit Securities Group first reported a position in CVS Health in Q2 2013 and has held it in 39 quarters since.
- Summit Securities Group's CVS Health position peaked at $10.1M in Q4 2021.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Summit Securities Group's 13F filing for Q2 2026, filed 3 Aug 2026.